| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 217,461 | 201,246 | 178,475 | 223,395 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 217,461 | 201,246 | 178,475 | 223,395 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 144,396 | 140,266 | 122,417 | 164,938 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 11,459 | 11,287 | 11,333 | 12,486 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 61,606 | 49,693 | 44,725 | 45,971 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,184) | 15,722 | 2,380 | 17,393 | | Earnings Before Interest And Taxes | 91,336 | 79,182 | 47,105 | (199,928) | | Interest Expense | 19,540 | 19,193 | 19,948 | 18,425 | | Income Before Tax | 71,796 | 59,989 | 27,157 | (218,353) | | Income Tax Expense | 3,936 | 3,740 | 3,917 | (42,751) | | Minority Interest |
-
|
-
|
-
| (19,720) | | | | Net Income From Continuing Ops | 3,419 | 56,249 | 23,240 | (69,751) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (44,616) | 56,249 | 23,240 | (69,751) | | Preferred Stock And Other Adjustments | 62,385 | (45,270) | (17,115) |
-
| | | Net Income Applicable To Common Shares | $17,769 | $10,979 | $6,125 | ($69,751) |
|
0.13% Nasdaq 
Income Statement
